Eye Institute Annual Fall Symposium and Celebration of the Gary W. Abrams Lectureship - SATURDAY ONLY
Overview
The aim of this program is to provide a comprehensive update on a variety of ophthalmic diseases, placing an emphasis on meeting the current challenges in diagnosis and management. Current challenges involve the use of anti-vascular endothelial growth factor agents in age-related macular degeneration, development of new approaches to treating retinal degenerative diseases, optic neuritis, epiphora, prophylaxis of infection in ophthalmic surgery, and recognition of ocular toxicity. Clinical implementation of diagnostic imaging modalities such as optical coherence tomography and adaptive optics imaging will also be discussed.
Because of the rapidity with which advancements in ophthalmic imaging technology, surgical instrumentation, and pharmacologic therapies have occurred, rational integration of these modalities into clinical practice has been challenging. To meet this challenge, clinicians must acquire an understanding of both the basic mechanisms underlying such modalities and the means by which they can be applied in a rational fashion to patient care. In addition, understanding of the underlying disease states must be acquired. These challenges remain for numerous subspecialty areas in ophthalmology.
Please note: a 4% processing fee will be assessed for all registrations.
There is a $50 cancellation fee.
Target Audience
This educational activity is aimed at practicing ophthalmologists, subspecialty ophthalmologists, optometrists, ophthalmology residents and fellows, medical students, vision scientists, photographers, ophthalmic nurses and technicians.
Learning Objectives
- Demonstrate a practical approach to the pharmacotherapy of age-related macular degeneration, ocular infection, and other retinal diseases
- Identify and illustrate a rational implementation of optical coherence tomography and other imaging modalities in ophthalmic care
- Describe key technological developments in area of vitreoretinal surgery and disease management
Venue
Crowne Plaza - Milwaukee West
10499 West Innovation Drive
Wauwatosa, WI 53226
Reservations: 414-475-9500
Faculty
Activity Director:
Dennis P. Han, MD
Jack A. & Elaine Klieger Professor of Ophthalmology
Speakers:
All persons in control of content have NO relevant financial relationships to disclose with the exception of the following persons:
Name | Company | Role |
H. Culver Boldt, MD | NA | NA |
Raymond Iezzi, MD, MS | Alimera Sciences | Consultant |
Alcon Surgical | Panel Member | |
Odette Houghton, MD | NA | NA |
Glen Jaffe, MD | Alcon/Novartis | Consultant |
Heidelberg | Consultant | |
Neurotech | Consultant | |
Judy Kim, MD | Optos | Support |
Genentech | Consultant | |
Allergan | Consultant | |
Kimberly Stepien, MD | NA | NA |
Mitchell Wolf, MD | NA | NA |
Gary Abrams, MD, FARVO | Alcon Research Institute Retrosense Therapeutics | Committee Royalties |
Neda Esmaili, MD | NA | NA |
Ryan Walsh, MD | NA | NA |
Edward Barnett, MD | NA | NA |
Dennis P. Han, MD
| Alcon | Consultant |
Flow One Healthcare | Consultant |
In accordance with the ACCME® Standards for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships. These relationships were reviewed via the MCW conflict of interest resolution process and resolved
Accreditation
Available Credit
- 4.75 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 4.75 Hours of ParticipationHours of Participation credit.
Register/Take course
Price
Do I already have an account?
Have you ever used ocpe.mcw.edu? For example, if you have taken an activity accredited by the Medical College of Wisconsin, then you already have an account.
If you have forgotten your username/password, you can
retrieve it now